TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

EMA Fails to Follow Legislation and Its Own Policy, page-4

  1. senoj
    2,617 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    05/11/14
    17:45
    Post #: 14240825
    I too suspect Big pharma have played a role in slowing our approval process. Several would have been evaluated as potential business partners only to be passed over in favour of Quintiles. I daresay they wanted too much. Subsequently they have stirred the pot to slow our approval process, show us how much influence they possess and how we missed out in not selecting one of them.
    TIS Price at posting: 31.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.